Sheng Wei-wei, Dong Ming, Zhou Jian-ping, Kong Fan-min, Li Yu-ji
Department of General Surgery, First Hospital, China Medical University, Shenyang, China.
Zhonghua Yi Xue Za Zhi. 2012 Dec 25;92(48):3407-11.
To explore the clinicopathological significance of the expression of carbonic anhydrase I (CAI) and carbonic anhydrase II (CAII) protein and mRNA levels in pancreatic ductal adenocarcinoma (PDAC).
The expression of CAI and CAII protein in 57 pairs of paraffin-embedded PDAC specimens and adjacent non-cancerous pancreatic tissues were detected by immunohistochemistry. The relationship between the protein expression and clinicopathological characters was analyzed. Western blot and quantitative real-time polymerase chain reaction (QRT-PCR) were used to examine the expression of CAI and CAII protein and mRNA levels in 16 paired fresh PDAC specimens, adjacent non-cancerous pancreatic tissues and 3 different differentiated pancreatic cancer cells (PANC-1, BxPC-3 & SW1990).
The expression of CAI protein was higher in PDAC compared with that in paired non-cancerous pancreatic tissues (t = 2.395, P = 0.020), whereas, CAII expression was significantly lower in PDAC than that in paired non-cancerous pancreatic tissues (t = 4.296, P = 0.000). The expression of CAI and CAII protein had a positive correlation with tumor differentiation (χ(2) = 7.557, P = 0.023; χ(2) = 7.822, P = 0.020) and CAI showed a direct negative correlation with vascular invasion (χ(2) = 6.349, P = 0.012). Univariate and multivariate analysis with clinicopathological characters revealed that the CAII expression was an independent prognostic indicator for PDAC patients (P = 0.017; P = 0.011 respectively). No significant difference of CAI mRNA and protein expression existed between PDAC and adjacent normal pancreatic tissues (t = 1.619, P = 0.126; t = 1.352, P = 0.197) as detected by Western blot and QRT-PCR, but the expression of CAII mRNA and protein levels was much lower in PDAC than that in paired non-cancerous pancreatic tissues, respectively (t = 3.360, P = 0.004; t = 2.934, P = 0.010). Moreover, the mRNA and protein expression of CAI and CAII gradually increased with the better differentiation degree of pancreatic cancer cells.
CAI is up-regulated and CAII down-regulated in PDAC. Both of them are correlated with tumor differentiation. CAII expression is an independent prognostic indicator for PDAC patients.
探讨碳酸酐酶I(CAI)和碳酸酐酶II(CAII)蛋白表达及mRNA水平在胰腺导管腺癌(PDAC)中的临床病理意义。
采用免疫组织化学法检测57对石蜡包埋的PDAC标本及癌旁非癌胰腺组织中CAI和CAII蛋白的表达。分析蛋白表达与临床病理特征之间的关系。采用蛋白质印迹法和定量实时聚合酶链反应(QRT-PCR)检测16对新鲜PDAC标本、癌旁非癌胰腺组织及3种不同分化程度的胰腺癌细胞(PANC-1、BxPC-3和SW1990)中CAI和CAII蛋白表达及mRNA水平。
与配对癌旁非癌胰腺组织相比,PDAC中CAI蛋白表达较高(t = 2.395,P = 0.020),而PDAC中CAII表达明显低于配对癌旁非癌胰腺组织(t = 4.296,P = 0.)。CAI和CAII蛋白表达与肿瘤分化呈正相关(χ(2) = 7.557,P = 0.023;χ(2) = 7.822,P = 0.020),且CAI与血管侵犯呈直接负相关(χ(2) = 6.349,P = 0.012)。对临床病理特征进行单因素和多因素分析显示,CAII表达是PDAC患者的独立预后指标(分别为P = 0.017;P = 0.011)。蛋白质印迹法和QRT-PCR检测显示,PDAC与癌旁正常胰腺组织之间CAI mRNA和蛋白表达无显著差异(t =1.619,P = 0.126;t = 1.352,P = 0.197),但PDAC中CAII mRNA和蛋白水平表达分别远低于配对癌旁非癌胰腺组织(t = 3.360,P = 0.004;t = 2.934,P = 0.010)。此外,随着胰腺癌细胞分化程度提高,CAI和CAII的mRNA和蛋白表达逐渐增加。
PDAC中CAI上调而CAII下调。二者均与肿瘤分化相关。CAII表达是PDAC患者的独立预后指标。